ReviewFrontiers in oncology2022

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer.

Matthew Alberto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.